VasoGenix Pharmaceuticals, Inc. Elects Former AVAX Technologies, Inc. CEO Richard P. Rainey to Its Board of Directors

February 3, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LENEXA, Kan.--(BUSINESS WIRE)--VasoGenix Pharmaceuticals announced today that Richard P. Rainey, CPA, former CEO of Avax Technologies, a publicly traded biotechnology company, has been elected to its board of directors.

Twitter
LinkedIn
Facebook
Email
Print

People